Frank Hoentjen
Overview
Explore the profile of Frank Hoentjen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
155
Citations
1715
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Madill-Thomsen K, Venner J, Parsons D, Famulski K, Thiesen A, Hoque S, et al.
Sci Rep
. 2025 Mar;
15(1):8342.
PMID: 40064933
The expanding portfolio of targeted therapies for ulcerative colitis (UC) suggests that a more precise approach to defining disease activity will aid clinical decision-making. This prospective study used genome-wide microarrays...
2.
Jansen F, den Broeder N, van Hal T, Mahler E, van Dop W, Hoentjen F
Eur J Gastroenterol Hepatol
. 2025 Feb;
PMID: 39975984
Background: Musculoskeletal manifestations occur in half of the patients with inflammatory bowel disease (IBD) and contribute to a reduced quality of life (QoL) and increased work disability. We aimed to...
3.
Te Groen M, Derks M, Nagtegaal I, Peters C, de Vries A, Dijkstra G, et al.
Eur J Gastroenterol Hepatol
. 2025 Feb;
37(3):287-294.
PMID: 39919003
Objective: The diagnosis of inflammatory bowel disease (IBD) associated with high-grade dysplasia (HGD) has a significant impact on clinical management, including colectomy. However, the prognosis of HGD remains unclear due...
4.
Ten Bokkel Huinink S, Bak M, Beelen E, Erler N, Silverberg M, Allez M, et al.
Aliment Pharmacol Ther
. 2025 Jan;
61(6):1019-1031.
PMID: 39856782
Background: The impact of prophylactic medication following ileocecal resection (ICR) for Crohn's disease (CD) merits further elucidation. Prophylactic medication following ileocecal resection (ICR) is recommended in patients with Crohn's disease...
5.
Shehab M, Al-Hindawi A, Alrashed F, Murthy S, Bisschops R, Hoentjen F, et al.
Aliment Pharmacol Ther
. 2025 Jan;
61(6):938-949.
PMID: 39825829
Background: Novel colorectal cancer endoscopic surveillance techniques for inflammatory bowel disease (IBD) have recently been developed. Aims: Compare the efficacy of currently available techniques for dysplasia detection in colonic IBD....
6.
Te Groen M, Wijnands A, den Broeder N, de Jong D, van Dop W, Duijvestein M, et al.
Gut
. 2025 Jan;
74(4):547-556.
PMID: 39819862
Background: It remains unclear if the increased colorectal neoplasia detection rate in inflammatory bowel disease (IBD) by high-definition (HD) dye-based chromoendoscopy compared with HD white-light endoscopy is due to enhanced...
7.
Siffledeen J, Hoentjen F
Dig Dis Sci
. 2024 Jul;
69(8):2725-2726.
PMID: 39078459
No abstract available.
8.
Derks M, Te Groen M, van Lierop L, Murthy S, Rubin D, Bessissow T, et al.
J Crohns Colitis
. 2024 May;
18(10):1726-1735.
PMID: 38741227
Inflammatory bowel disease [IBD] patients are at increased risk of developing colorectal neoplasia [CRN]. In this review, we aim to provide an up-to-date overview and future perspectives on CRN management...
9.
van Linschoten R, Jansen F, Pauwels R, Smits L, Atsma F, Kievit W, et al.
Dig Dis Sci
. 2024 Apr;
69(6):2165-2174.
PMID: 38594435
Background: In the pragmatic open-label randomised controlled non-inferiority LADI trial we showed that increasing adalimumab (ADA) dose intervals was non-inferior to conventional dosing for persistent flares in patients with Crohn's...
10.
Halloran B, Reeson M, Teshima C, Kroeker K, Huang V, Dieleman L, et al.
Therap Adv Gastroenterol
. 2024 Mar;
17:17562848241230904.
PMID: 38425369
Background: Despite recent emerging literature involving the utility of endoscopic balloon dilation (EBD) of strictures balloon-assisted endoscopy (BAE), specifically regarding the management of Crohn's disease (CD), the optimal clinical approach...